The study, coordinated by Vall d'Hebron, aims to facilitate access to personalized medicine for all children and adolescents with cancer, regardless of where they live.

It is the project “New Nanotechnological Therapy for Parkinson’s disease: Nose to Brain Delivery of GBA-Polymer Nanoconjugates (nanoGBAtoBrain)”.

Entre els projectes es troben 12 investigacions on participen investigadors i investigadores de Vall d’Hebron.

En les consultes de la Unitat de Tractament Integral de l’Obesitat de Vall d’Hebron els avenços de la recerca estan molt presents, ja sigui en forma d’assaig clínic o mitjançant la utilització d’unes ulleres de realitat virtual.

Onze investigadors i investigadores de Vall d’Hebron faran xerrades i tallers amb l’objectiu d’apropar la ciència a tothom.

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

Researchers have presented advances in the field of myocardial infarction, non-compaction cardiomyopathy and genetic aortic pathology, in addition to hosting a meeting between international experts on vascular aging.

The different members of the network met in Vall d’Hebron to share their innovations processes, needs, challenges, and goals

The international study incorporates new magnetic resonance markers to increase sensitivity in the diagnosis of this disease.

The paper that analyzed to what degree the most commonly prescribed immunosuppressants increase the likelihood of melanoma was considered the best communication at the national congress of dermatology

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

The research team on liver transplantation in children led by Dr. Jesús Quintero has received two awards for the best oral communications and a grant.

The Kidney Transplantation Unit of Vall d'Hebron Hospital was the first European center to include patients in the post-authorization efficacy study, the step prior to approval by the European Medicines Agency.

The paper presents the consensus among 16 experts from around the world analyzing the impact of ECMO during the pandemic.

Six Vall d'Hebron researchers have participated in the meeting organized by the Fetal Medicine Foundation.

The research, published in The Lancet, studied patients in Barcelona and Madrid, and shows that direct contact is the main route of transmission for the disease.

The international study in which Vall d'Hebron participated has found that these women may experience a lower health-related quality of life regardless of how long ago the abuse occurred.

His project reports the increased diagnostic power of high-resolution bowel manometry in patients with suspected small bowel motor disorder compared to conventional technology.

A study published in the Journal of Healthcare Quality Research describes the transformation process at the Vall d’Hebron University Hospital in response to the first few months of the COVID-19 pandemic.

The HepClink project, started in 2019, has been effective in reaching an immigrant population with low knowledge of the disease and that, in general, has not been tested before

Es tracta d'un projecte pioner a l'Estat que ha permès detectar més de 128 persones amb el virus actiu, de les quals 40 han estat tractades i curades.

Vall d'Hebron is one of the participants in the CARB-ES-19 research, led by the CIBER, in which 71 hospitals throughout the peninsula have collaborated.

The researcher Carles Rubio presented the research of the VHIR Microbiology research group and the UPC and co-funded by the Probitas Foundation.

Dr. Luz Uria was recognized for the best communication of the Congress of the Sociedad Española de Hematología y Oncología Pediátrica, the second place was for Dr. Raquel Hladun.